Further, the co-delivery of doxorubicin (Dox) and p53 by deionized chitosan derivative functionalized MSNs tempted noteworthy apoptosis in breast cancer cells due to the synergistic effects of Dox and the p53 gene [18]. The gene discussed is TP53; the disease is breast carcinoma.